Caudal Block Versus Dorsal Penile Nerve Block Plus Ring Block for Pain Management of Different Surgical Techniques of Circumcision in Infants and Children

January 31, 2022 updated by: Mansoor Aqil, King Saud University
Circumcision is one of the most commonly performed operations in the pediatric population and is a painful procedure. Circumcision is performed with two popular techniques, Plastibell and conventional dissection method (CDM). For intra-operative (OP) and post-OP pain relief, two commonly used local anesthetic techniques are caudal block (CB) and dorsal penile block (DPNB) plus ring block (RB) at the base of the penis. There are very few randomized controlled trials comparing these two methods of intra-OP and post-OP pain relief, for different surgical techniques and there is a lack of well-conducted studies comparing the quality of analgesia, need for rescue analgesia in the early post-OP period, complications, and parental satisfaction comparing these blocks. Furthermore, there is a lot of contradiction in the literature regarding the duration of analgesia produced with these techniques.

Study Overview

Detailed Description

Circumcision is one of the most commonly performed operations in the paediatric population and is a painful procedure. Circumcision is performed with two popular techniques, Plastibell and conventional dissection method. Two anesthetic techniques are commonly used for intra-operative (OP) and post-OP pain relief i.e CB and DPNB+RB at the base of the penis. Addition of dexmedetomidine to bupivacaine prolongs duration of analgesia of CB. Both anaesthesia techniques of pain relief have certain advantages and disadvantages and the superiority of any technique over the other has not been established.

There are very few randomized controlled trials comparing these two methods of intra-OP and post-OP pain relief, for different surgical techniques of circumcision and there is a lack of well-conducted studies comparing the quality of analgesia, need for rescue analgesia in the early post-OP period, complications, and parental satisfaction comparing these blocks. Furthermore, there is a lot of contradiction in the literature regarding the duration of analgesia produced with these techniques.

Poorly treated postoperative pain leads to fatigue and metabolic, endocrine, and immunological changes can lead to prolonged convalescence following surgery and is traumatic to the pediatric patients and their parents. In this study, the investigators planned to compare the two most popular methods of pain relief during and after circumcision, along with parents' satisfaction.

This research will guide the anesthetists regarding the selection of appropriate techniques of intra-OP and post-OP analgesia and in light of intra and post-OP data; and parents' satisfaction.

In this prospective randomized study the investigators plan to compare the quality of intra and post OP analgesia and the duration of post-OP analgesia produced by CB and DPNB +RB, need of rescue analgesia with both of the techniques of surgery, intra-OP hemodynamic variations, residual motor block, and adverse effects and parents' satisfaction with both of the anesthesia and the surgical techniques.

Research Objectives:

To evaluate and compare the intra and post-OP pain relief under CB and DPNB plus RB in pediatric patients undergoing circumcision with different surgical techniques and assessment of parents' satisfaction

This study may guide the anesthetists for the selection of appropriate techniques of intra and post-OP analgesia and their complications for different surgical techniques of circumcision and also about parent's satisfaction with the anesthetic technique.

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Riyadh, Saudi Arabia
        • King Saud University
        • Contact:
        • Principal Investigator:
          • Mansoor Aqil
        • Sub-Investigator:
          • Abdulrahman Alzahem
        • Sub-Investigator:
          • Mueen ullah Khan
        • Sub-Investigator:
          • Fatma Dammas
        • Sub-Investigator:
          • Abdulaziz Ahmed
        • Sub-Investigator:
          • Abdul Sattar Narejo
        • Sub-Investigator:
          • Rashid Saeed Khokhar

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 6 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  1. Healthy,
  2. Male,
  3. Ages 3 months to 4 years,
  4. Scheduled for circumcision for various indications under GA.

Exclusion Criteria:

  1. Patients with bleeding or clotting disorders
  2. Patients with hypospadias, other penile or sacral anomalies
  3. Patients weight <3kg.
  4. Allergy to Local Anesthetic
  5. Infection at the site of block
  6. Pre-existing spinal or neurological disease
  7. Pain medication within the previous 48 hours

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Caudal block and circumcision with Plastibell,
Caudal block will be performed with 0.75ml/kg of 0.25% bupivacaine containing 1 mic/kg dexmedetomidine. Circumcision will be done using plastibell. Paracetamol suppository will also be inserted per rectum in the dose of 15 mg/kg before the start of surgery. The surgery will be started 10 minutes after block placement to allow adequate time for the block to be effective.
Caudal block will be performed in lateral position with 0.25% bupivacaine in the dose of 0.75 ml/kg containing 1 mic/kg dexmedetomidine. The patients will be turned back to the supine position after the block placement and the head of the patient will be placed in the neutral position. Paracetamol suppository will also be inserted per rectum in the dose of 15 mg/kg before the start of surgery. The surgery will be started 10 minutes after block placement to allow adequate time for the block to be effective.
Circumcision with Plastibell
Experimental: Caudal block and circumcision with conventional dissection method
Caudal block will be performed with 0.75ml/kg of 0.25% bupivacaine containing 1 mic/kg dexmedetomidine. Circumcision will be done using the conventional dissection method. Paracetamol suppository will also be inserted per rectum in the dose of 15 mg/kg before the start of surgery. The surgery will be started 10 minutes after block placement to allow adequate time for the block to be effective.
Caudal block will be performed in lateral position with 0.25% bupivacaine in the dose of 0.75 ml/kg containing 1 mic/kg dexmedetomidine. The patients will be turned back to the supine position after the block placement and the head of the patient will be placed in the neutral position. Paracetamol suppository will also be inserted per rectum in the dose of 15 mg/kg before the start of surgery. The surgery will be started 10 minutes after block placement to allow adequate time for the block to be effective.
Conventional Dissection Method
Active Comparator: Dorsal penile nerve block plus ring block and circumcision with Plastibell
Dorsal penile nerve block plus ring block with 0.25% bupivacaine. Circumcision will be done using plastibell.
Circumcision with Plastibell
It will be performed with the child in the supine position. Following skin preparation and palpation of the arch of the lower border of the symphysis pubis, the base of the penis will be gently pulled down, and a 25-G needle will be inserted at 10 and 2.0 "O" clock position to a depth of 0.25-0.5 cm (under Bucks' fascia) and 1 ml + 0.1ml X weight of the patient) of local anesthetic (0.25% bupivacaine) will be injected at each point after negative aspiration and then RB will be done in the form of a circumferential subcutaneous ring at the level of the base of the penis. Paracetamol suppository will also be inserted per rectum in the dose of 15 mg/kg before the start of surgery. The surgery will be started 10 minutes after block placement to allow adequate time for the block to be effective.
Active Comparator: Dorsal penile nerve block plus ring block and circumcision with conventional dissection method
Dorsal penile nerve block plus ring block with 0.25% bupivacaine. Circumcision will be done using the conventional dissection method
Conventional Dissection Method
It will be performed with the child in the supine position. Following skin preparation and palpation of the arch of the lower border of the symphysis pubis, the base of the penis will be gently pulled down, and a 25-G needle will be inserted at 10 and 2.0 "O" clock position to a depth of 0.25-0.5 cm (under Bucks' fascia) and 1 ml + 0.1ml X weight of the patient) of local anesthetic (0.25% bupivacaine) will be injected at each point after negative aspiration and then RB will be done in the form of a circumferential subcutaneous ring at the level of the base of the penis. Paracetamol suppository will also be inserted per rectum in the dose of 15 mg/kg before the start of surgery. The surgery will be started 10 minutes after block placement to allow adequate time for the block to be effective.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Efficacy of analgesia using FLACC Scale
Time Frame: First 12 hours after surgery/intervention (circumcision)
Postoperatively in the PACU, the child will be observed in the recovery room by a senior nurse blinded to the anesthetic technique and the FLACC score will be used for pain assessment (copy attached). The FLACC scale is a uni-dimensional behavioral pain assessment instrument to measure pain in young children in the post-OP period. It includes five items (Face, Leg, Activity, Cry, and Consolability) and has good inter-rater reliability (Kappa 0.52-0.82), as well as good content and convergent validity. The scale is scored in a range of 0-10 with 0 = no pain and 10 = severe pain. The FLACC is reliable in critically ill young children. The severity of pain will be classified using the total score 0=no pain, and 10= severe pain. I.V fentanyl will be administered in the dose of 0.5 mic/kg if the pain score is >5 and the dose will be repeated if the FLACC score persisted >5 after five minutes.
First 12 hours after surgery/intervention (circumcision)
Duration of analgesia
Time Frame: First 12 hours after surgery/intervention (circumcision)
To compare the duration of post-OP analgesia produced by CB and DPNB plus RB in children undergoing circumcision with two different surgical techniques.
First 12 hours after surgery/intervention (circumcision)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants that needed rescue analgesia
Time Frame: first 12 hours after surgery (circumcision)
Number of participants that needed rescue analgesia in PACU and ward
first 12 hours after surgery (circumcision)
Motor block score
Time Frame: first 12 hours after surgery (circumcision)
Motor block score will be recorded (0=spontaneous movements of hips, knees and ankles, 1=movements of knees and ankles but no movements of hips, 2=only movements of ankles, and 3=no movements of lower limbs).
first 12 hours after surgery (circumcision)
Blood pressure (mm/Hg)
Time Frame: during the surgery (from start time to end time of circumcision)
Patients will receive fentanyl 0.5 mic/kg, if at any stage HR or BP increased 25% more than baseline value and the total dose of rescue analgesia received intra-operatively will be recorded.
during the surgery (from start time to end time of circumcision)
Heart rate (beats/min)
Time Frame: during the surgery (from start time to end time of circumcision)
Patients will receive fentanyl 0.5 mic/kg, if at any stage HR or BP increased 25% more than baseline value and the total dose of rescue analgesia received intra-operatively will be recorded.
during the surgery (from start time to end time of circumcision)
Time to discharge from PACU
Time Frame: First 12 hours after surgery (circumcision)
Amount of time the patient stays in PACU after the surgery. This will be a continuous variable (time).
First 12 hours after surgery (circumcision)
Number of patients with infection
Time Frame: First 5 days after surgery (circumcision)
Number of patients experiencing infection at site of circumcision. It will be recorded as yes/no.
First 5 days after surgery (circumcision)
Number of patients experiencing urinary retention
Time Frame: First 12 hours after surgery (circumcision)
Measured as: no urine output after intervention.
First 12 hours after surgery (circumcision)
Number of Participants with sedation
Time Frame: First 12 hours after surgery: assessed at 5, 15, and 30 minutes in PACU and hourly in the ward
Sedation will be measured using the The Pasero Opioid-Induced Sedation Scale (POSS). POSS is a standardized approach to assessing opioid-induced sedation and instituting interventions. The POSS scores are S ("sleep, easy to arouse"), 1 ("awake and alert"), 2 ("slightly drowsy, easily aroused"), 3 ("frequently drowsy, arousable, drifts off to sleep during conversation"), and 4 ("somnolent, minimal, or no response to verbal or physical stimulation"). Scores of S, 1, or 2 are considered acceptable; the opioid dose may be increased if needed.
First 12 hours after surgery: assessed at 5, 15, and 30 minutes in PACU and hourly in the ward
Number of Participants with nausea
Time Frame: First 12 hours after surgery: assessed at 5, 15, and 30 minutes in PACU and hourly in the ward
Will be recorded as yes/no
First 12 hours after surgery: assessed at 5, 15, and 30 minutes in PACU and hourly in the ward
Number of Participants with vomiting
Time Frame: First 12 hours after surgery: assessed at 5, 15, and 30 minutes in PACU and hourly in the ward
Will be recorded as yes/no
First 12 hours after surgery: assessed at 5, 15, and 30 minutes in PACU and hourly in the ward
Number of Participants with agitation
Time Frame: First 12 hours after surgery: assessed at 5, 15, and 30 minutes in PACU and hourly in the ward
Will be recorded as yes/no
First 12 hours after surgery: assessed at 5, 15, and 30 minutes in PACU and hourly in the ward
Number of Participants with penile hematoma
Time Frame: First 12 hours after surgery/intervention: assessed at 5, 15, and 30 minutes in PACU and hourly in the ward
Will be recorded as yes/no
First 12 hours after surgery/intervention: assessed at 5, 15, and 30 minutes in PACU and hourly in the ward
Total paracetamol doses administered
Time Frame: first 5 days after surgery (circumcision)
Amount of paracetamol required by the patient for pain control
first 5 days after surgery (circumcision)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parents' satisfaction with pain relief using Likert Scale
Time Frame: First 5 days after surgery (circumcision)
Parents' satisfaction with pain relief will be measured using a Likert Scale (0-10)
First 5 days after surgery (circumcision)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mansoor Aqil, FCPS, King Saud University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

March 1, 2022

Primary Completion (Anticipated)

March 1, 2023

Study Completion (Anticipated)

March 1, 2023

Study Registration Dates

First Submitted

October 22, 2021

First Submitted That Met QC Criteria

January 31, 2022

First Posted (Actual)

February 10, 2022

Study Record Updates

Last Update Posted (Actual)

February 10, 2022

Last Update Submitted That Met QC Criteria

January 31, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • E-21-5965

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Clinical Trials on Caudal block

Subscribe